pharmaphorum

FEBRUARY 10, 2022

With staff shortages and digital skill gaps being experienced across the spectrum of healthcare, from CROs and pharma to providers, the people-led sector is facing a personnel challenge that could threaten the potential of digital transformation. The healthcare ecosystem may be the natural beneficiary of recent advances in data collection and analysis, but that’s no use without the staff to develop and implement solutions.

Compounding 105

Compounding 105

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education. It’s no longer enough to build brand awareness, according to the panelists.

Communication 98

Communication 98

pharmaphorum

FEBRUARY 10, 2022

Amazon has passed another milestone in the rollout of its healthcare business, makings it telehealth service available nationwide in the US and adding another 20 cities to its in-person services. The online retail giant first started offering the Amazon Care service to some of its own employees in 2019, expanding it to all its US workforce in 2021 and offering it to other organisations, including recently the Hilton hotel chain.

Vaccines 104

Vaccines 104

Outsourcing Pharma

FEBRUARY 10, 2022

In the first of a two-part series, leaders from the CRO discuss how study data has progressed in recent years and how trial teams can keep up effectively.

83

83

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 10, 2022

The FDA has granted fast-track status to Bayer’s oral Factor Xia inhibitor asundexian, which is in phase 2 testing as an anticoagulant that could offer safety advantages over current drugs. Asundexian (also known as BAY2433334) will be given a speedy review by the US regulator as a secondary preventative treatment for people with ischaemic stroke, specifically those with non- cardioembolic risk factors like narrowed arteries.

FDA 98

FDA 98

Outsourcing Pharma

FEBRUARY 10, 2022

The pharmaceutical company, which uses thin-film freezing to develop inhalable therapies, has completed enrollment in the first phase for its drug candidate.

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Marketing Network

FEBRUARY 10, 2022

Innovative social media marketers from top life sciences companies discussed the secrets to their success at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about pharma social media trends in 2022: 1. Don’t be afraid to try new things. Social media trends change all the time, and pharma marketing organizations have to be nimble to make the most of them, according to Lauren Sacks , Director of Omnichannel Marketing at Biohaven Pharmaceu

52

52

pharmaphorum

FEBRUARY 10, 2022

Japanese drugmaker Eisai has published comments filed with the US Centers for Medicare & Medicaid Services over its restrictive coverage proposal for beleaguered Alzheimer’s drug Aduhelm, saying it undermines well-established FDA processes. The letter to CMS’ director of coverage and analysis Tamara Syrek Jensen said the decision to impose a coverage with evidence development (CED) on Biogen-partnered Aduhelm (aducanumab) – effectively limiting use of the drug to approved clinica

FDA 59

FDA 59

Pharma Marketing Network

FEBRUARY 10, 2022

Change champions from top life sciences companies discussed how to manage the constant wave of change pharma marketing teams are facing at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about preparing your pharma marketing team for change in 2022: 1. Your marketing best practices still apply!

52

52

pharmaphorum

FEBRUARY 10, 2022

Digital health is transforming the way that we approach healthcare, but how can companies make the most of this new multi-channel engagement model? Dr Paul Tunnah sits down with a panel of experts at the 2021 Frontiers Health conference to learn more about innovation opportunities in the sector. There are very few instances where an entire industry is forced to reimagine its primary working model almost overnight.

Communication 52

Communication 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

FEBRUARY 10, 2022

Innovative social media marketers from top life sciences companies discussed the secrets to their success at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about pharma social media trends in 2022: 1. Don’t be afraid to try new things. Social media trends change all the time, and pharma marketing organizations have to be nimble to make the most of them, according to Lauren Sacks , Director of Omnichannel Marketing at Biohaven Pharmaceu

52

52

pharmaphorum

FEBRUARY 10, 2022

The 3rd Protein Degradation and Targeting Undruggables Summit is North America’s only in-person, industry-led conference covering clinical progress and commercial scale development of first-in-class degrader technology platforms. Our agenda will cover the key drug development challenges for this therapeutic modality including assessing diverse targets, improving selectivity and delivery to disease-relevant proteins.

52

52

Pharma Marketing Network

FEBRUARY 10, 2022

Change champions from top life sciences companies discussed how to manage the constant wave of change pharma marketing teams are facing at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about preparing your pharma marketing team for change in 2022: 1. Your marketing best practices still apply!

52

52

pharmaphorum

FEBRUARY 10, 2022

CVS Health has said it will beef up its clinical trials operations, improving its ability to recruit patients from a broad demographic spectrum, via an agreement with digital health company Medable. CVS will harness Medable’s decentralised trials software, deploying it in thousands of CVS MinuteClinics across the US, to create a network that could unlock access to clinical research studies for millions of Americans, according to the healthcare group.

Insurance 52

Insurance Vaccines 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Marketing Network

FEBRUARY 10, 2022

Innovative social media marketers from top life sciences companies discussed the secrets to their success at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about pharma social media trends in 2022: 1. Don’t be afraid to try new things. Social media trends change all the time, and pharma marketing organizations have to be nimble to make the most of them, according to Lauren Sacks , Director of Omnichannel Marketing at Biohaven Pharmaceu

52

52

pharmaphorum

FEBRUARY 10, 2022

AstraZeneca confirmed today that it has discontinued clinical development of a follow-up to its COVID-19 vaccine Vaxzevria targeted at the Beta variant of the virus, which started development before the emergence of the Delta and Omicron strains. The new vaccine – codenamed AZD2816 – started phase 2/3 trials as a booster dose for people vaccinated with Vaxzevria or mRNA vaccines from Pfizer/BioNTech and Moderna last June, when Beta was still the dominant SARS-CoV-2 variant of concern.

Vaccines 52

Vaccines Immunization FDA 52

Pharma Times

FEBRUARY 10, 2022

Research demonstrates that people who live with peanut allergies face isolation and discrimination

46

46

pharmaphorum

FEBRUARY 10, 2022

FDA advisors have voted against approval of Eli Lilly and Innovent Biologics’ cancer immunotherapy sintilimab, undermining hopes of a new, lower-priced option in the PD-1/PD-L1 inhibitor class. The Oncologic Drugs Advisory Committee (ODAC) followed the line laid out by the agency’s reviewer in briefing documents published earlier this week, and voted 14 to 1 against approving the drug as first-line treatment for non-squamous non-small cell lung cancer (NSCLC).

FDA 52

FDA Documentation 52

Pharma Times

FEBRUARY 10, 2022

Diurnal’s pioneering phase 2 study evaluates modified-release hydrocortisone for adrenal insufficiency

40

40